Sarah C. Gilbert

Active 1994–2025

Also published as
Sarah C Gilbert
181
Papers
38,371
Citations
93
h-index
180
i10-index

Citations

Citations per year for Sarah C. Gilbert1974: 1 citations1994: 1 citations1995: 2 citations1996: 6 citations1997: 8 citations1998: 31 citations1999: 70 citations2000: 62 citations2001: 64 citations2002: 68 citations2003: 77 citations2004: 125 citations2005: 185 citations2006: 156 citations2007: 85 citations2008: 129 citations2009: 142 citations2010: 135 citations2011: 200 citations2012: 176 citations2013: 251 citations2014: 146 citations2015: 198 citations2016: 158 citations2017: 151 citations2018: 94 citations2019: 465 citations2020: 1,384 citations2021: 5,464 citations2022: 3,299 citations2023: 925 citations2024: 892 citations2025: 296 citations2026: 7 citations1975–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,250 citing papers, 20.9% of this breakdownUnited Kingdom: 1,911 citing papers, 12.3% of this breakdownChina: 937 citing papers, 6% of this breakdownGermany: 717 citing papers, 4.6% of this breakdownAustralia: 527 citing papers, 3.4% of this breakdownIndia: 512 citing papers, 3.3% of this breakdownItaly: 494 citing papers, 3.2% of this breakdownFrance: 467 citing papers, 3% of this breakdownCanada: 432 citing papers, 2.8% of this breakdownNetherlands: 413 citing papers, 2.7% of this breakdownSpain: 311 citing papers, 2% of this breakdownSwitzerland: 300 citing papers, 1.9% of this breakdown
0%20.9%Other 33.9%

Fields

  • Medicine76%
  • Immunology and Microbiology9%
  • Biochemistry, Genetics and Molecular Biology6.7%
  • Social Sciences2.7%
  • Mathematics1.6%
  • Agricultural and Biological Sciences1%
  • Other3%

Topics

  • SARS-CoV-2 and COVID-19 Research19.9%
  • COVID-19 Clinical Research Studies8.8%
  • Vaccine Coverage and Hesitancy4.5%
  • vaccines and immunoinformatics approaches4.4%
  • Immunotherapy and Immune Responses3.2%
  • Animal Virus Infections Studies2.9%
  • Other56.3%

Coauthors

All papers

Open in search
  1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick Lillie, Raburn M. Mallory, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F Mujadidi, Anusha Nana, Peter O’Reilly, Sherman D. Padayachee, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Alexandre Vargas Schwarzbold, Nisha Singh, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Richard Tarrant, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Marion Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Fatola Abayomi, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Yemi Adelaja, Gbadebo Adewetan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Thamires C. D. S. C Almeida and 665 more - The Lancet 2020 cited by 5,010

  2. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah C. Gilbert, Andrew J. Pollard, Jeremy Aboagye, K. F. Adams, Aabidah Ali, Elizabeth Allen, Jennifer L. Allison, Rachel Anslow, Edward H. Arbe-Barnes, Gavin Babbage, J. Kenneth Baillie, Megan Baker, Natalie Baker, Philip Baker, Ioana Baleanu, Juliana Ballaminut, Eleanor Barnes, Jordan R. Barrett, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Eleanor Berrie, Lisa Berry, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Tracey Bingham, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Thomas Bower, Amy Boyd, Tanja Brenner, Philip Bright, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Sharon Burge, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabera Puig, Anna Calvert, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Victoria Carter, Katrina Cathie, Ruth Challis, Sue Charlton, Irina Chelysheva, Jee-Sun Cho, Paola Cicconi, Liliana Cifuentes, Helen Clark, Elizabeth Clark, Tom Cole, Rachel Colin-Jones, Christopher P. Conlon, Aislinn Cook, Naomi S. Coombes, Rachel Cooper, Catherine A. Cosgrove, Karen Coy, Wendy E.M. Crocker, Christina J. Cunningham and 265 more - The Lancet 2020 cited by 2,614

  3. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Beveridge, Kevin R. Bewley, Phillip J. Brown, Emily Brunt, Karen R. Buttigieg, Susana Camara, Sue Charlton, Emily Chiplin, Paola Cicconi, Elizabeth Clutterbuck, Andrea M. Collins, Naomi S. Coombes, Sue Ann Costa Clemens, M. Davison, Tesfaye Demissie, Tanya Dinesh, Alexander D. Douglas, C.J. Duncan, Katherine R. W. Emary, Katie Ewer, Sally Felle, Daniela M. Ferreira, Adam Finn, Pedro M. Folegatti, Ross Fothergill, Sara Fraser, Harriet Garlant, Laura Gatcombe, Kerry Godwin, Anna L. Goodman, Christopher Green, Bassam Hallis, Thomas C. Hart, Paul T. Heath, Helen Hill, Adrian V. S. Hill, Daniel Jenkin, Mwila Kasanyinga, Simon Kerridge, Chanice Knight, Stephanie Leung, Vincenzo Libri, Patrick Lillie, Spyridoula Marinou, Joanna McGlashan, Alastair McGregor, Lorna McInroy, Angela M. Minassian, Yama F Mujadidi, Elizabeth J. Penn, Christos J. Petropoulos, Katrina M. Pollock, Pamela C. Proud, Samuel Provstgaard-Morys, Durga Rajapaska, Maheshi Ramasamy, Katherine Sanders, Imam H. Shaik, Nisha Singh, Andrew Smith, Matthew D. Snape, Rinn Song, Sonu Shrestha, Rebecca Sutherland, Emma C. Thomson, David P. J. Turner, Alice Webb-Bridges, Terri Wrin, Christopher J. Williams - Nature Medicine 2021 cited by 1,239

  4. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Green, Christopher Green, Melanie Greenland, Catherine Hill, Helen Hill, Ian Hirsch, Alane Izu, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Natalie G. Marchevsky, Richard P. Marshall, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Anusha Nana, Sherman D. Padayachee, Daniel J. Phillips, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Adam Ritchie, Hannah Robinson, Alexandre Vargas Schwarzbold, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Thomas White, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Gbadebo Adewatan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Felipe B. Alvernaz, Fabio Santos Amorim, Claudia Sala Andrade, Foteini Andritsou, Rachel Anslow and 666 more - The Lancet 2021 cited by 1,208

  5. Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

    Authors: , , , , - Scientific Reports 2017 cited by 264

  6. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J. Kelly, Tonya Villafana, Sarah C. Gilbert, Andrew J. Pollard, Túlio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu - New England Journal of Medicine 2021 cited by 1,321

  7. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jamie Lovaglio, Patrick W. Hanley, Dana Scott, Greg Saturday, Emmie de Wit, Sarah C. Gilbert, Vincent J. Munster - Nature 2020 cited by 993

  8. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

    Authors: , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 267

  9. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth J Kelly, Simon Kerridge, Alison M Lawrie, Alice Lelliott, May N Lwin, Rebecca Makinson, Natalie G Marchevsky, Yama Mujadidi, Alasdair P S Munro, Mihaela Pacurar, Emma Plested, Jade Rand, Thomas Rawlinson, Sarah Rhead, Hannah Robinson, Adam J Ritchie, Amy L Ross-Russell, Stephen Saich, Nisha Singh, Catherine C Smith, Matthew D Snape, Rinn Song, Richard Tarrant, Yrene Themistocleous, Kelly M Thomas, Tonya L Villafana, Sarah C Warren, Marion E E Watson, Alexander D Douglas, Adrian V S Hill, Teresa Lambe, Sarah C Gilbert, Saul N Faust, Andrew J Pollard, Jeremy Aboagye, Kelly Adams, Aabidah Ali, Elizabeth R. Allen, Lauren Allen, Jennifer L. Allison, Foteini Andritsou, Rachel Anslow, Edward H. Arbe-Barnes, Megan Baker, Natalie Baker, Philip Baker, Ioana Baleanu, Debbie Barker, Eleanor Barnes, Jordan R. Barrett, Kelly Barrett, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Duncan Bellamy, Adam Berg, Laura Bermejo, Eleanor Berrie, Amy Beveridge, Kevin Bewley, Else M. Bijker, Geeta Birch, Luke Blackwell, Heather Bletchly, Caitlin L. Blundell, Susannah R. Blundell, Emma Bolam, Elena Boland, Daan Bormans and 321 more - The Lancet 2020 cited by 1,405

  10. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Rinn Song, Matthew D. Snape, Richard Tarrant, Merryn Voysey, Marion Watson, Alexander D. Douglas, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Teresa Lambe, the Oxford COVID Vaccine Trial Group, Aabidah Ali, Elizabeth Allen, Megan Baker, Eleanor Barnes, Nicola Borthwick, Amy Boyd, Charlie Brown-O’Sullivan, Joshua Burgoyne, Nicholas Byard, Ingrid Cabrera Puig, Federica Cappuccini, Jee-Sun Cho, Paola Cicconi, Elizabeth Clark, Wendy E.M. Crocker, Mehreen S. Datoo, H. Dele Davies, Francesca R. Donnellan, Susanna Dunachie, Nick J. Edwards, Sean C. Elias, Julie Furze, Ciarán Gilbride, Giacomo Gorini, Gaurav Gupta, Stephanie A. Harris, Susanne H. Hodgson, Mimi M. Hou, Susan Jackson, Kathryn Jones, Reshma Kailath, Lloyd D. W. King, Colin W. Larkworthy, Yuanyuan Li, Amelia M. Lias, Aline Linder, Samuel Lipworth, Raquel Lopez Ramon, Meera Madhavan, Emma Marlow, Julia L. Marshall, Alexander J. Mentzer, Hazel Morrison, Nathifa Moya, Ekta Mukhopadhyay, Andrés Noé, Fay L. Nugent, Dimitra Pipini, David Pulido-Gomez, Fernando Ramos Lopez, Adam Ritchie, Indra Rudiansyah, Stephannie Salvador and 184 more - Nature Medicine 2020 cited by 643

  11. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Flaxman, Mustapha Bittaye, Sandra Belij‐Rammerstorfer, Sarah C. Gilbert, William James, Miles W. Carroll, Paul Klenerman, Eleanor Barnes, Susanna Dunachie, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin Screaton - Cell 2021 cited by 1,158

  12. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julian C. Knight, Derrick W. Crook, Teresa Lambe, Elizabeth Clutterbuck, Sagida Bibi, Amy Flaxman, Mustapha Bittaye, Sandra Belij‐Rammerstorfer, Sarah C. Gilbert, Tariq Malik, Miles W. Carroll, Paul Klenerman, Eleanor Barnes, Susanna Dunachie, Vicky L. Baillie, Natali Serafin, Zanele Ditse, Kelly da Silva, Neil G. Paterson, Mark A. Williams, David R. Hall, Shabir A. Madhi, Marta C. Nunes, Philip Goulder, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin Screaton - Cell 2021 cited by 751

  13. Antibody evasion by the P.1 strain of SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Clutterbuck, Sagida Bibi, Amy Flaxman, Mustapha Bittaye, Sandra Belij‐Rammerstorfer, Sarah C. Gilbert, Miles W. Carroll, Paul Klenerman, Eleanor Barnes, Susanna Dunachie, Neil G. Paterson, Mark A. Williams, David R. Hall, Ruben J. G. Hulswit, Thomas A. Bowden, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin Screaton - Cell 2021 cited by 662

  14. A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

    Authors: , , , , , , , - PLoS ONE 2012 cited by 394

  15. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bassam Hallis, Paul T. Heath, Jodie Hay, Helen Hill, Daniel Jenkin, Simon Kerridge, Rajeka Lazarus, Vincenzo Libri, Patrick Lillie, Catherine Ludden, Natalie G. Marchevsky, Angela M. Minassian, Alastair McGregor, Yama F Mujadidi, Daniel J. Phillips, Emma Plested, Katrina M. Pollock, Hannah Robinson, Darren Smith, Rinn Song, Matthew D. Snape, Rebecca Sutherland, Emma C. Thomson, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Christopher J. Williams, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Merryn Voysey, Maheshi Ramasamy, Andrew J. Pollard - The Lancet 2021 cited by 651

  16. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert H. Levin, Tao Dong, Andrew J. Pollard, Julian C. Knight, Paul Klenerman, Derrick W. Crook, Teresa Lambe, Elizabeth Clutterbuck, Sagida Bibi, Amy Flaxman, Mustapha Bittaye, Sandra Belij‐Rammerstorfer, Sarah C. Gilbert, David R. Hall, Mark A. Williams, Neil G. Paterson, William James, Miles W. Carroll, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin Screaton - Cell 2021 cited by 529

  17. CD4+ T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4+ Cells

    Authors: , , , , , , , , , , , , , - Cell Reports 2020 cited by 121

  18. T‐cell‐inducing vaccines – what’s the future

    Authors: - Immunology 2011 cited by 171

  19. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca Makinson, Jack Mellors, Angela M. Minassian, Maria Moore, Yama F Mujadidi, Emma Plested, Ian Poulton, Maheshi Ramasamy, Hannah Robinson, Christine S. Rollier, Rinn Song, Matthew D. Snape, Richard Tarrant, Stephen Taylor, Kelly Thomas, Merryn Voysey, Marion Watson, Daniel Wright, Alexander D. Douglas, Catherine Green, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, the Oxford COVID Vaccine Trial Group, Jeremy Aboagye, Jennifer Alderson, Aabidah Ali, Elizabeth Allen, Lauren Allen, Rachel Anslow, Carolina V. Arancibia-Cárcamo, Edward H. Arbe-Barnes, Megan Baker, Philip Baker, Natalie Baker, Ioana Baleanu, Eleanor Barnes, Louise Bates, Alexander Batten, Kirsten Beadon, Rebecca Beckley, Amy Beveridge, Kevin R. Bewley, Else M. Bijker, Luke Blackwell, Caitlin L. Blundell, Emma Bolam, Elena Boland, Nicola Borthwick, Amy Boyd, Tanja Brenner, Philip N. Brown, Charlie Brown-O’Sullivan, Emily Brunt, Jamie Burbage, Karen R. Buttigieg, Nicholas Byard, Ingrid Cabrera Puig, Susana Camara, Michelangelo Cao, Federica Cappuccini, Melanie Carr, Miles W. Carroll, Jim Chadwick, Irina Chelysheva, Jee-Sun Cho, Liliana Cifuentes, Elizabeth Clark, Rachel Colin-Jones and 203 more - Nature Medicine 2020 cited by 340

  20. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rinn Song, Danielle Woods, Gavin Screaton, Sarah C. Gilbert, Merryn Voysey, Andrew J. Pollard, Teresa Lambe, Syed Adlou, Robert Aley, Aabidah Ali, Rachel Anslow, Megan Baker, Phillip Baker, Jordan R. Barrett, Louise Bates, Kirsten Beadon, Rebecca Beckley, Jonathan Bell, Duncan Bellamy, Amy Beveridge, Cameron Bissett, Luke Blackwell, Heather Bletchly, Amy Boyd, Alice Bridges-Webb, Charlie Brown, Nicholas Byard, Susana Camara, Liliana Cifuentes Gutierrez, Andrea M. Collins, Rachel Cooper, Wendy E.M. Crocker, Thomas C. Darton, H. Dele Davies, J Davies, Tesfaye Demissie, Claudio Di Maso, Tanya Dinesh, Francesca R. Donnellan, Alexander D. Douglas, Rachael Drake-Brockman, C.J. Duncan, Sean C. Elias, Katherine R. W. Emary, Mutjaba Farooq, Saul N. Faust, Sally Felle, Daniela M. Ferreira, Carla Ferreira Da Silva, Adam Finn, Karen Ford, Emma Francis, Julie Furze, Michelle Fuskova, Eva Galiza, Ana Gibertoni Cruz, Leila Godfrey, Anna L. Goodman, Catherine Green, Christopher Green, Nicola M. Greenwood, Daisy Harrison, Thomas C. Hart, Sophia Hawkins, Paul T. Heath, Helen Hill, Kushalinii Hillson, Bryn Horsington, Mimi M. Hou, Elizabeth Howe and 87 more - The Lancet 2021 cited by 258

  21. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters

    Authors: , , , , , , , , , , , , , , - PLoS neglected tropical diseases 2019 cited by 85

  22. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanna Nguyen, Lucia Parolini, Claire Petersen, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Hannah Robinson, Nicola Robinson, Patpong Rongkard, Fiona Ryan, Sonia Serrano, Timothy Tipoe, Merryn Voysey, Anele Waters, Panagiota Zacharopoulou, Eleanor Barnes, Susanna Dunachie, Philip Goulder, Paul Klenerman, Gavin Screaton, Alan Winston, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Sarah Fidler, Julie Fox, Teresa Lambe, Marion Watson, Rinn Song, Paola Cicconi, Angela M. Minassian, Sagida Bibi, Simon Kerridge, Nisha Singh, Catherine Green, Alexander D. Douglas, Alison M. Lawrie, Elizabeth Clutterbuck - The Lancet HIV 2021 cited by 256

  23. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 236

  24. Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Microbe 2021 cited by 59